Tag: GI
Cell & gene therapy market set to grow at 44% CAGR...
Significant advancements in treatments for gastrointestinal (GI) disorders are anticipated, driven by innovations from both large and small pharma companies, says GlobalData
Respiratory disease with 15.3% burden highest in India, reveals study by...
Asthma contributes 10% of all respiratory diseases and has seen a more moderate increase over the past 10 years
FUJIFILM India launches CAD EYE function for upper gastrointestinal diagnosis at...
The new CAD EYE™ Upper GI enables early detection of cancer in the Upper Gastrointestinal tract. India is the second country where the technology is being introduced after Japan